News
Hosted on MSN21d
Fragmented care does not affect survival outcomes for retroperitoneal sarcoma, says researchIn a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and ...
To define the optimal initial management and the best extent of surgery that would optimize margins on primary retroperitoneal sarcomas (RPS). Patients and Methods A total of 382 patients with primary ...
This study focused on retroperitoneal sarcoma, a soft tissue sarcoma which develops in the back of the abdomen and, due to its location and rarity, is currently hard to diagnose and treat.
In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and ...
Fragmented care — receiving medical treatment at more than one facility — has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such ...
The most concerning possibility with this finding is a rare condition called retroperitoneal sarcoma (RPS). It is quite rare, affecting about 2.7 people in a million. You are quite right that a ...
surgery alone in high-risk retroperitoneal sarcoma; the Brightline study investigating brigimadlin vs. standard doxorubicin in liposarcoma; and the prospective INSIGHT study looking at whether ...
Get Instant Summarized Text (Gist) Fragmented care for retroperitoneal sarcoma, involving treatment at multiple facilities, leads to longer delays and greater travel distances but does not impact ...
This study focused on retroperitoneal sarcoma, a soft tissue sarcoma which develops in the back of the abdomen and, due to its location and rarity, is currently hard to diagnose and treat. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results